Global Therapeutic Protein Market Insights, Forecast to 2025

Description

Therapeutic proteins are the engineered proteins in the laboratory intended for pharmaceutical use.
Geographically, North America is the dominating region in the Therapeutic Protein market owing to the greater research and development work on therapeutic proteins going on in the North America and Europe.
The global Therapeutic Protein market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Therapeutic Protein market based on company, product type, end user and key regions.

This report studies the global market size of Therapeutic Protein in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Therapeutic Protein in these regions.
This research report categorizes the global Therapeutic Protein market by top players/brands, region, type and end user. This report also studies the global Therapeutic Protein market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen
Abbott Laboratories
AstraZeneca
Baxter International
Boehringer Ingelheim
Chugai Pharmaceutical
Diasome Pharmaceuticals
Eli Lilly
GeneScience Pharmaceuticals
Generex Biotechnology
Genentech

Market size by Product
Monoclonal Antibodies
Erythropoietin
Insulin
Interferon
Human Growth Hormone
Follicle Stimulating Hormone
Blood Clotting Factors
Market size by End User
Pharmaceutical Companies
Healthcare Service Providers
Research Organizations
Academic Research Institutes

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Therapeutic Protein market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Therapeutic Protein market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Therapeutic Protein companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Therapeutic Protein submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Therapeutic Protein are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Therapeutic Protein market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Study Coverage
1.1 Therapeutic Protein Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Therapeutic Protein Market Size Growth Rate by Product
1.4.2 Monoclonal Antibodies
1.4.3 Erythropoietin
1.4.4 Insulin
1.4.5 Interferon
1.4.6 Human Growth Hormone
1.4.7 Follicle Stimulating Hormone
1.4.8 Blood Clotting Factors
1.5 Market by End User
1.5.1 Global Therapeutic Protein Market Size Growth Rate by End User
1.5.2 Pharmaceutical Companies
1.5.3 Healthcare Service Providers
1.5.4 Research Organizations
1.5.5 Academic Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Therapeutic Protein Market Size
2.1.1 Global Therapeutic Protein Revenue 2014-2025
2.1.2 Global Therapeutic Protein Sales 2014-2025
2.2 Therapeutic Protein Growth Rate by Regions
2.2.1 Global Therapeutic Protein Sales by Regions
2.2.2 Global Therapeutic Protein Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Therapeutic Protein Sales by Manufacturers
3.1.1 Therapeutic Protein Sales by Manufacturers
3.1.2 Therapeutic Protein Sales Market Share by Manufacturers
3.1.3 Global Therapeutic Protein Market Concentration Ratio (CR5 and HHI)
3.2 Therapeutic Protein Revenue by Manufacturers
3.2.1 Therapeutic Protein Revenue by Manufacturers (2014-2019)
3.2.2 Therapeutic Protein Revenue Share by Manufacturers (2014-2019)
3.3 Therapeutic Protein Price by Manufacturers
3.4 Therapeutic Protein Manufacturing Base Distribution, Product Types
3.4.1 Therapeutic Protein Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Therapeutic Protein Product Type
3.4.3 Date of International Manufacturers Enter into Therapeutic Protein Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Therapeutic Protein Sales by Product
4.2 Global Therapeutic Protein Revenue by Product
4.3 Therapeutic Protein Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Therapeutic Protein Breakdown Data by End User

6 North America
6.1 North America Therapeutic Protein by Countries
6.1.1 North America Therapeutic Protein Sales by Countries
6.1.2 North America Therapeutic Protein Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Therapeutic Protein by Product
6.3 North America Therapeutic Protein by End User

7 Europe
7.1 Europe Therapeutic Protein by Countries
7.1.1 Europe Therapeutic Protein Sales by Countries
7.1.2 Europe Therapeutic Protein Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Therapeutic Protein by Product
7.3 Europe Therapeutic Protein by End User

8 Asia Pacific
8.1 Asia Pacific Therapeutic Protein by Countries
8.1.1 Asia Pacific Therapeutic Protein Sales by Countries
8.1.2 Asia Pacific Therapeutic Protein Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Therapeutic Protein by Product
8.3 Asia Pacific Therapeutic Protein by End User

9 Central & South America
9.1 Central & South America Therapeutic Protein by Countries
9.1.1 Central & South America Therapeutic Protein Sales by Countries
9.1.2 Central & South America Therapeutic Protein Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Therapeutic Protein by Product
9.3 Central & South America Therapeutic Protein by End User

10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Protein by Countries
10.1.1 Middle East and Africa Therapeutic Protein Sales by Countries
10.1.2 Middle East and Africa Therapeutic Protein Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Therapeutic Protein by Product
10.3 Middle East and Africa Therapeutic Protein by End User

11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Company Business Overview
11.1.3 Amgen Therapeutic Protein Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen Therapeutic Protein Products Offered
11.1.5 Amgen Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Company Business Overview
11.2.3 Abbott Laboratories Therapeutic Protein Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Abbott Laboratories Therapeutic Protein Products Offered
11.2.5 Abbott Laboratories Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 Company Business Overview
11.3.3 AstraZeneca Therapeutic Protein Sales, Revenue and Gross Margin (2014-2019)
11.3.4 AstraZeneca Therapeutic Protein Products Offered
11.3.5 AstraZeneca Recent Development
11.4 Baxter International
11.4.1 Baxter International Company Details
11.4.2 Company Business Overview
11.4.3 Baxter International Therapeutic Protein Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Baxter International Therapeutic Protein Products Offered
11.4.5 Baxter International Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Company Business Overview
11.5.3 Boehringer Ingelheim Therapeutic Protein Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Boehringer Ingelheim Therapeutic Protein Products Offered
11.5.5 Boehringer Ingelheim Recent Development
11.6 Chugai Pharmaceutical
11.6.1 Chugai Pharmaceutical Company Details
11.6.2 Company Business Overview
11.6.3 Chugai Pharmaceutical Therapeutic Protein Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Chugai Pharmaceutical Therapeutic Protein Products Offered
11.6.5 Chugai Pharmaceutical Recent Development
11.7 Diasome Pharmaceuticals
11.7.1 Diasome Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Diasome Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Diasome Pharmaceuticals Therapeutic Protein Products Offered
11.7.5 Diasome Pharmaceuticals Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Company Business Overview
11.8.3 Eli Lilly Therapeutic Protein Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Eli Lilly Therapeutic Protein Products Offered
11.8.5 Eli Lilly Recent Development
11.9 GeneScience Pharmaceuticals
11.9.1 GeneScience Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 GeneScience Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2014-2019)
11.9.4 GeneScience Pharmaceuticals Therapeutic Protein Products Offered
11.9.5 GeneScience Pharmaceuticals Recent Development
11.10 Generex Biotechnology
11.10.1 Generex Biotechnology Company Details
11.10.2 Company Business Overview
11.10.3 Generex Biotechnology Therapeutic Protein Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Generex Biotechnology Therapeutic Protein Products Offered
11.10.5 Generex Biotechnology Recent Development
11.11 Genentech

12 Future Forecast
12.1 Therapeutic Protein Market Forecast by Regions
12.1.1 Global Therapeutic Protein Sales Forecast by Regions 2019-2025
12.1.2 Global Therapeutic Protein Revenue Forecast by Regions 2019-2025
12.2 Therapeutic Protein Market Forecast by Product
12.2.1 Global Therapeutic Protein Sales Forecast by Product 2019-2025
12.2.2 Global Therapeutic Protein Revenue Forecast by Product 2019-2025
12.3 Therapeutic Protein Market Forecast by End User
12.4 North America Therapeutic Protein Forecast
12.5 Europe Therapeutic Protein Forecast
12.6 Asia Pacific Therapeutic Protein Forecast
12.7 Central & South America Therapeutic Protein Forecast
12.8 Middle East and Africa Therapeutic Protein Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Therapeutic Protein Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Choose License Type

Checkout Inquiry Sample